Introduction: Pseudohypoparathyroidism, newly classified as inactivating PTH/PTHrP signaling disorder (iPPSD) type 2 or type 3, is a rare disease caused by defects in the GNAS imprinted gene that encodes Gsα. The most common phenotype comprises resistance to hormones binding to G protein-coupled receptors such as PTH, PTHrP, or TSH, subcutaneous ossifications, short stature, brachydactyly, and early onset obesity. Uncommon features have been described including sleep apnea, asthma, and resistance to calcitonin. At the national French reference center for rare calcium and phosphate metabolism diseases, a large cohort of patients with iPPSD type 2 and type 3 is followed. Interestingly, digestive manifestations and in particular intractable constipation were regularly reported by families of children with iPPSD type 2 or type 3. Objective: The aim of our study was therefore to specify the frequency and characteristics of digestive manifestations in children followed up for iPPSD2 or iPPSD3 in our reference center. Material and Methods: Thirty-six patients aged between 2 and 18 years (32 followed up for iPPSD2 and 4 for iPPSD3) were included. Parents completed a specific questionnaire to assess any digestive disorders in their child. The diagnosis of constipation was established using the Bristol visual scale in the event of a score of less than 2 according to stool appearance. Results: Parents reported constipation through the questionnaires in 22/36 (over 60%) of the children. It was the most frequently reported digestive disorder. Among these 22 children, 19 (87%) had a Bristol score for stool shape and texture between 1 and 2 on a scale of 7, confirming constipation. Dedicated treatment had been initiated for 10 (55%) of them, yet only 3 families (16%) considered this treatment effective. Neonatal vomiting and eating disorders, such as lack of satiety or food selectivity, were also noted in 18 (50%) of patients, as was gastroesophageal reflux present in the neonatal period in 14 (40%) of children. There were no significant differences according to the type of iPPSD or patient age. Conclusion: Our work shows for the first time that digestive manifestations, including constipation, occur frequently in children followed for iPPSD, suggesting a potential role of Gsα and G protein receptors in the digestive tract. It is well known that constipation and digestive symptoms alter quality of life. Early management is therefore essential to improve the quality of life of children followed for iPPSD. Our data need to be confirmed on a larger cohort.

1.
Mantovani
G
,
Bastepe
M
,
Monk
D
,
de Sanctis
L
,
Thiele
S
,
Usardi
A
, et al
.
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
.
Nat Rev Endocrinol
.
2018
;
14
(
8
):
476
500
.
2.
Thiele
S
,
Mantovani
G
,
Barlier
A
,
Boldrin
V
,
Bordogna
P
,
De Sanctis
L
, et al
.
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network
.
Eur J Endocrinol
.
2016
;
175
(
6
):
P1
17
.
3.
Turan
S
,
Bastepe
M
.
GNAS spectrum of disorders
.
Curr Osteoporos Rep
.
2015
;
13
(
3
):
146
58
.
4.
Barlow
DP
,
Bartolomei
MS
.
Genomic imprinting in mammals
.
Cold Spring Harb Perspect Biol
.
2014
;
6
(
2
):
a018382
.
5.
Weinstein
LS
,
Xie
T
,
Zhang
Q-H
,
Chen
M
.
Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology
.
Pharmacol Ther
.
2007
;
115
(
2
):
271
91
.
6.
Turan
S
,
Bastepe
M
.
The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene
.
Horm Res Paediatr
.
2013
;
80
(
4
):
229
41
.
7.
Turan
S
.
Current nomenclature of pseudohypoparathyroidism: inactivating parathyroid hormone/parathyroid hormone-related protein signaling disorder
.
J Clin Res Pediatr Endocrinol
.
2017
;
9
(
Suppl 2
):
58
68
.
8.
Campbell
R
,
Gosden
CM
,
Bonthron
DT
.
Parental origin of transcription from the human GNAS1 gene
.
J Med Genet
.
1994
;
31
(
8
):
607
14
.
9.
Reimann
F
,
Tolhurst
G
,
Gribble
FM
.
G-protein-coupled receptors in intestinal chemosensation
.
Cell Metab
.
2012
;
15
(
4
):
421
31
.
10.
Weis
WI
,
Kobilka
BK
.
The molecular basis of G protein-coupled receptor activation
.
Annu Rev Biochem
.
2018
;
87
:
897
919
.
11.
Carbone
SE
,
Veldhuis
NA
,
Gondin
AB
,
Poole
DP
.
G protein-coupled receptor trafficking and signaling: new insights into the enteric nervous system
.
Am J Physiol Gastrointest Liver Physiol
.
2019
;
316
(
4
):
G446
52
.
12.
Qin
X
,
Liu
S
,
Lu
Q
,
Zhang
M
,
Jiang
X
,
Hu
S
, et al
.
Heterotrimeric G stimulatory protein α subunit is required for intestinal smooth muscle contraction in mice
.
Gastroenterology
.
2017
;
152
(
5
):
1114
25.e5
.
13.
Kim
HG
,
Lee
KJ
,
Lim
SG
,
Jung
JY
,
Cho
SW
.
G-protein Beta3 subunit C825T polymorphism in patients with overlap syndrome of functional dyspepsia and irritable bowel syndrome
.
J Neurogastroenterol Motil
.
2012
;
18
(
2
):
205
10
.
14.
De Vadder
F
,
Mithieux
G
.
Contrôle de la glycémie par l’axe nerveux intestin-cerveau
.
Med Sci
.
2015
;
31
(
2
):
168
73
.
15.
Yang
M
,
Fukui
H
,
Eda
H
,
Xu
X
,
Kitayama
Y
,
Hara
K
, et al
.
Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility
.
Am J Physiol Gastrointest Liver Physiol
.
2017
;
312
(
4
):
G367
73
.
16.
Avelar Rodriguez
D
,
Popov
J
,
Ratcliffe
EM
,
Toro Monjaraz
EM
.
Functional constipation and the gut microbiome in children: preclinical and clinical evidence
.
Front Pediatr
.
2020
;
8
:
595531
.
17.
Halim
MA
,
Degerblad
M
,
Sundbom
M
,
Karlbom
U
,
Holst
JJ
,
Webb
D-L
, et al
.
Glucagon-like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans
.
J Clin Endocrinol Metab
.
2018
;
103
(
2
):
575
85
.
18.
Marsaud
C
,
Rossignol
S
,
Tounian
P
,
Netchine
I
,
Dubern
B
.
Prevalence and management of gastrointestinal manifestations in Silver-Russell syndrome
.
Arch Dis Child
.
2015
;
100
(
4
):
353
8
.
20.
Blake
MR
,
Raker
JM
,
Whelan
K
.
Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome
.
Aliment Pharmacol Ther
.
2016
;
44
(
7
):
693
703
.
21.
Gulati
R
,
Komuravelly
A
,
Leb
S
,
Mhanna
MJ
,
Ghori
A
,
Leon
J
, et al
.
Usefulness of assessment of stool form by the modified Bristol stool form scale in primary care pediatrics
.
Pediatr Gastroenterol Hepatol Nutr
.
2018
;
21
(
2
):
93
100
.
22.
Del Sindaco
G
,
Berkenou
J
,
Pagnano
A
,
Rothenbuhler
A
,
Arosio
M
,
Mantovani
G
, et al
.
Neonatal and early infancy features of patients with inactivating PTH/PTHrP signaling disorders/pseudohypoparathyroidism
.
J Clin Endocrinol Metab
.
2023
;
108
(
11
):
2961
9
.
23.
Usardi
A
,
Mamoune
A
,
Nattes
E
,
Carel
J-C
,
Rothenbuhler
A
,
Linglart
A
.
Progressive development of PTH resistance in patients with inactivating mutations on the maternal allele of GNAS
.
J Clin Endocrinol Metab
.
2017
;
102
(
6
):
1844
50
.
24.
Campeotto
F
,
Barbaza
M-O
,
Hospital
V
.
Functional gastrointestinal disorders in outpatients aged up to 12 Months: a French non-interventional study
.
Int J Environ Res Public Health
.
2020
;
17
(
11
):
4031
.
25.
Heuckeroth
RO
.
Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes
.
Nat Rev Gastroenterol Hepatol
.
2018
;
15
(
3
):
152
67
.
26.
Turcotte
M-C
,
Faure
C
.
Pediatric intestinal pseudo-obstruction: progress and challenges
.
Front Pediatr
.
2022
;
10
:
837462
.
27.
Dimidi
E
,
Christodoulides
S
,
Scott
SM
,
Whelan
K
.
Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation
.
Adv Nutr
.
2017
;
8
(
3
):
484
94
.
28.
Kuhlmann
L
,
Joensson
IM
,
Froekjaer
JB
,
Krogh
K
,
Farholt
S
.
A descriptive study of colorectal function in adults with Prader-Willi Syndrome: high prevalence of constipation
.
BMC Gastroenterol
.
2014
;
14
:
63
.
30.
Giabicani
E
,
Pham
A
,
Sélénou
C
,
Sobrier
M-L
,
Andrique
C
,
Lesieur
J
, et al
.
Dental pulp stem cells as a promising model to study imprinting diseases
.
Int J Oral Sci
.
2022
;
14
(
1
):
19
.
31.
Tabbers
MM
,
DiLorenzo
C
,
Berger
MY
,
Faure
C
,
Langendam
MW
,
Nurko
S
, et al
.
Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN
.
J Pediatr Gastroenterol Nutr
.
2014
;
58
(
2
):
258
74
.
You do not currently have access to this content.